According to Zack’s Research, the most bullish Wall Street analyst has a short term price target of $96 on shares of DaVita healthCare Partners Inc. (NYSE:DVA). When taking into account all of the research brokerage firms surveyed by Zacks, the consensus target price is currently $87.714. This is based on the 7 providing 12-month projections on the shares. On the contrary, the most bearish, or conservative analyst has a one-year target of $80.
Zacks uses an average brokerage recommendation (ABR) rating system in order to provide a simplified scale for understanding the calculated average of the actual Buy, Sell, Hold ratings made by research analysts. A stock is given a rating between 1 and 5 where 1 represents a Strong Buy and 5 a Strong Sell. DaVita healthCare Partners Inc. (NYSE:DVA) shares currently have a Zacks ABR of 1.91 .
One of the most important indicators for future stock movement is a company’s earnings. Most recently, DaVita healthCare Partners Inc. (NYSE:DVA) reported earnings per share of $0.97 for the fiscal quarter ended on 2015-06-30. This resulted in a surprise factor of 1.06%, or $0.01 away from the latest Zacks consensus estimates just prior to the earnings announcement.
For the current quarter, analysts are anticipating earnings around $0.97 per share. This is the current consensus number based on the 7 analysts taken into consideration by Zacks.
DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysia’s Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.